Risk of Progression of Subclinical to Overt Hypothyroidism: A Cohort Study
DOI:
https://doi.org/10.21276/apalm.3648Keywords:
Ferritin, thyroid stimulating hormone, subclinical hypothyroidism, overt hypothyroidism, euthyroidismAbstract
Background: Subclinical hypothyroidism is defined by elevated serum thyroid stimulating hormone levels in the setting of normal levels of the thyroxine (T4) and triiodothyronine (T3). Iron acts as a cofactor in Thyroid peroxidase, which catalyses the initial two reactions of T3 and T4 biosynthesis. The chief clinical marker of iron deficiency is serum ferritin, which reflects the body iron stores. Whether hypoferritinemia affects the development of overt hypothyroidism from subclinical hypothyroidism is a question of concern.
Methods: Aim: To determine the predictive significance of serum ferritin in subclinical hypothyroidism. Material and method: A cohort observational study was carried out at Adesh Institute of Medical Sciences and Research (AIMSR), Bathinda, India from June 2023 to December 2024 in Biochemistry department in collaboration with Medicine department, among 95 subjects of subclinical hypothyroidism attending the medicine outpatient department.
Results: A total of 29 (30.53%) patients of subclinical hypothyroidism were converted to overt hypothyroidism by the end of 6 months. While in subjects with normal ferritin levels (>30µg/L) and low ferritin levels (15-30 µg/L) the conversion of subclinical hypothyroidism (TSH=7.09±1.33 µIU/mL) in normal ferritin subgroup, TSH=7.23±1.74 µIU/mL in low ferritin subgroup) to overt hypothyroidism (TSH=8.73±4.31 µIU/mL in normal ferritin subgroup, TSH=13.02±8.26 µIU/mL in low ferritin subgroup) was non-significant with p values p=0.51 and p=0.06) respectively. The conversion of subclinical hypothyroidism ( TSH=8.02±1.34 µIU/m) to overt hypothyroidism (TSH =13.86±8.49 µIU/mL) was significant (p=0.005) in subclinical hypothyroid patients with very low ferritin levels (<15 µg/L.
Conclusion: Monitoring and correcting ferritin levels could be important in managing subclinical hypothyroidism to prevent progression.
References
1. Chaker L, Razvi S, Bensenor IM, Azizi F, Pearce EN, Peeters RP. Hypothyroidism. Nat Rev Dis Primers. 2022 May 19:8(1):30. https://doi.org/10.1038/s41572-022-00357-7
2. Krishnamurthy HK, Reddy S, Jayaraman V. Krishna K, Song Q, Rajasekaran KE, et al. Association of Serum Ferritin Levels and Thyroid Hormones, Open J Clin Diagn [Internet]. 2023 Aug 4 [cited 2023 Dec 19]:13(3):68-79. doi: 10.4236/ojcd.2023.133007.
3. Sue LY, Leung AM. Levothyroxine for the Treatment of Subclinical Hypothyroidism and Cardiovascular Disease. Front Endocrinol (Lausanne). 2020;11:591588. https://doi.org/10.3389/fendo.2020.591588
4. Krishnamurthy HA, Ravitej S. Predictive Significance of High Sensitive C-reactive Protein in Subclinical Hypothyroidism: A Prospective Observational Study. J Clin Diagn Res. 2022;16(10):OC15-OC17. https://www.doi.org/10.7860/JCDR/2022/58886/16998
5. Garofalo V, Condorelli RA, Cannarella R, Aversa A, Calogero AE, La Vignera S. Relationship between iron deficiency and thyroid function: A systematic review and meta-analysis. Nutrients. 2023 15(22):4790. Doi.org/10.3390/nu15224790.
6. Eftekhari MH, Simondon KB, Jalali M, Keshavarz SA, Elguero E, Eshraghian MR, et al. Effects of administration of iron, iodine and simultaneous iron-plus-iodine on the thyroid hormone profile in iron-deficient adolescent Iranian girls. Eur J Clin Nutr. 2006:60:545-52. doi: 10.1038/sj.ejcn.1602349.
7. Ravanbod M, Asadipooya K, Kalantarhormozi M, Nabipour I, Omrani GR. Treatment of iron-deficiency anemia in patients with subclinical hypothyroidism. Am J Med. 2013;126:420-4. doi: 10.1016/j.amjmed.2012.12.009.
8. Cinemre H, Bilir C, Gokosmanoglu F. Bahcebasi T. Hematologic effects of levothyroxine in iron-deficient subclinical hypothyroid patients: A randomized, double-blind, controlled study. J Clin Endocrinol Metab. 2009;94:151-6. doi: 10.1210/jc.2008-1440.
9. Swapnika TG, Sabitha Rani SS. Dipankar S, Itagi ABH, Vamshidhar IS. A comparative study of iron status in subclinical hypothyroid and euthyroid subjects in a tertiary care hospital. Cureus. 2024;16(1):e52007. Doi: 10.7860/cureus.52007.
10. Uakarn C, Kajohnsak C, Sintao N. Sample size estimation using Yamane and Cochran and Krejcie and Morgan and Green formulas and Cohen statistical power analysis by G*Power and comparisons. Apheit International Journal. 2021;10(2).
11. Daru J, Allotey J, Peña-Rosas JP, Khan KS. Serum ferritin thresholds for the diagnosis of iron deficiency in pregnancy: a systematic review: Serum ferritin for defining iron deficiency in pregnancy. Transfus Med. 2017:27:167-74.
12. Soppi ET. Iron deficiency without anemia a clinical challenge. Clin Case Rep. 2018;6:1082-6.
13. Krishna DS, Kumari JA, Sreedevi NN, Khan SA, Bhaskar MV, Babapu KSS, et al. Iron Deficiency and Hypoferritinaemia in Patients with Subclinical Hypothyroidism: A Retrospective Observational Study. J Clin Diagn Res. 2024 Jun;18(6):BC07-BC11.
14. Ravanbod M, Asadipooya K. Kalantarhormozi M, Nabipour I, Omrani GR. Treatment of Iron-deficiency Anemia in Patients with Subclinical Hypothyroidism. Am J Med. 2013;126(5):420-4.
15. Soppi E. Iron deficiency is the main cause of symptom persistence in patients treated for hypothyroidism. Thyroid. 2015;25:A74.
16. Szklarz M, Gontarz-Nowak K, Matuszewski W, et al. Iron: Not Just a Passive Bystander in AITD. Nutrients. 2022;14(21):4682. doi: 10.3390/nu14214682.
17. Gierach M, Rudewicz M, Junik R. Iron and ferritin deficiency in women with hypothyroidism and chronic lymphocytic thyroiditis - systematic review. Endokrynol Pol. 2024;75(3):253-61. https://doi.org/10.5603/ep.97860.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Premjeet Kaur, Rakendra Singh
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access at http://opcit.eprints.org/oacitation-biblio.html).
